"What's new in esophageal surgery?"

April 27, 2017

Presener: Doug Liou, MD 

Planner: Hon Lee, MD, John Stevenson, MD, Maihgan A Kavanagh, MD

Target Audience

Gastroenterologist, general surgeons, Hemotology oncologists, thoracic surgeons

    Learning Objectives

     

    1. escribe the role of neoadjuvant therapy in esophageal surgery
    2. Point to the role of NSQIP outcomes data in understanding risk of esophageal surgery.

     

    Course summary
    Available credit: 
    • 1.00 AMA PRA Category 1 Credit(s)™
    Course opens: 
    04/27/2017
    Course expires: 
    04/27/2017
    Event starts: 
    04/27/2017 - 12:30pm
    Event ends: 
    04/27/2017 - 1:30pm
    Rating: 
    0
    MOB C1&2
    United States

    Disclosure: The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.

    Kaiser Santa Clara is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Santa Clara designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Available Credit

    • 1.00 AMA PRA Category 1 Credit(s)™
    Please login or register to take this course.